pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,525 catalysts · 3,350 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 66 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-02×clear all
type
  • 8k filing3,350
  • grant1,096
  • device adverse event1,000
  • earnings580
  • approval550
  • device 510k430
  • device pma248
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 9, 2026

    50
    ›Mar 10, 2026grant158d agoYALE UNIVERSITY — Regulation of infant social behaviors and learning by the zona incerta

    MH grant. $838,378. PI: Marcelo Dietrich

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoWEILL MEDICAL COLL OF CORNELL UNIV — Transcriptional control by autism associated H3K9 methylation regulators duri...

    MH grant. $800,667. PI: Matthias Stadtfeld

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoDANA-FARBER CANCER INST — The Fourth International Merkel Cell Carcinoma Symposium

    AR grant. $20,000. PI: Ann W. Silk

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoDREXEL UNIVERSITY — Investigating molecular mechanisms of glutamate toxicity in HIV-1 Tat-induced...

    MH grant. $49,416. PI: Brenna Duffy

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoDUKE UNIVERSITY — Functions and mechanisms of metalloenzymes in natural product and cofactor bi...Duke University

    GM grant. $737,152. PI: Kenichi Yokoyama

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoOHIO STATE UNIVERSITY — Oligosaccharide cross-feeding and competition in microbial communities

    GM grant. $375,898. PI: Darryl A Wesener

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Intersectional analysis of the Whole Person Care-Los Angeles social care inte...University of California Los Angeles

    DK grant. $616,107. PI: Sae Takada

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoHARVARD UNIVERSITY — Examining the processes that deform bacterial membranes to initiate cell divi...

    GM grant. $1,600,449. PI: Ethan Clark Garner

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoVERSITI BLOOD HEALTH, INC. — Decoding kindlin-3 signaling in platelets and neutrophils

    HL grant. $1,069,072. PI: Yan-Qing Ma

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoUNIVERSITY OF MISSOURI KANSAS CITY — Addressing Food Access and Physcial Activity to Improve Diabetes Prevention O...

    DK grant. $847,068. PI: JENIFER ELIZABETH ALLSWORTH

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoDUKE UNIVERSITY — Real-Time, Longitudinal, Functional Brain Imaging via 4D Smart Epidermal Phot...Duke University

    EB grant. $722,392. PI: Xiaoyue Ni

    full page →nih reporter ↗
    ›Mar 10, 2026grant158d agoGORDON RESEARCH CONFERENCES — 2026 Autophagy in Stress, Development and Disease Gordon Research Conference ...

    CA grant. $4,000. PI: Rushika Miriam Perera

    full page →nih reporter ↗
    ›Mar 11, 2026approval157d agoLABETALOL HYDROCHLORIDE — FDA approvalHikma Pharmaceuticals USA Inc

    Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval157d agoTESTOSTERONE — FDA approvalTransdermal Delivery Solutions Corp

    Sponsor: ENCUBE. Form: GEL, METERED. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval157d agoDOXYCYCLINE — FDA approvaldoxycycline ER

    Sponsor: STRIDES PHARMA INTL. Form: CAPSULE. Route: ORAL

    full page →doxycycline ER →fda approvals ↗
    ›Mar 11, 2026approval157d agoCEVIMELINE HYDROCHLORIDE — FDA approvalCEVIMELINE HYDROCHLORIDE

    Sponsor: ZYDUS LIFESCIENCES. Form: CAPSULE. Route: ORAL

    full page →CEVIMELINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 11, 2026approval157d agoLIRAGLUTIDE — FDA approvalSaxenda

    Sponsor: BIOCON PHARMA. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →Saxenda →fda approvals ↗
    ›Mar 11, 2026approval157d agoOMEPRAZOLE — FDA approvalomeprazole DR

    Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

    full page →omeprazole DR →fda approvals ↗
    ›Mar 11, 2026approval157d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

    Sponsor: LABORATORIOS GRIFOLS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 11, 2026approval157d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

    Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →choline fenofibrate →fda approvals ↗
    ›Mar 11, 2026approval157d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

    Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →choline fenofibrate →fda approvals ↗
    ›Mar 11, 2026approval157d agoOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

    Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

    full page →dexamethasone LA →fda approvals ↗
    ›Mar 11, 2026approval157d agoLANSOPRAZOLE — FDA approvallansoprazole DR

    Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

    full page →lansoprazole DR →fda approvals ↗
    ›Mar 11, 2026approval157d agoFERRIC CITRATE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval157d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval157d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval157d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval157d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval157d agoAPHEXDA (MOTIXAFORTIDE ACETATE) — FDA approvalBioLineRx Ltd.

    Sponsor: AYRMID PHARMA. Form: POWDER. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Mar 11, 2026approval157d agoBRIMONIDINE TARTRATE — FDA approvalLumify

    Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Lumify →fda approvals ↗
    ›Mar 11, 2026recall157d agoCipla USA, Inc. recall (Cls III)Cipla USA Inc

    Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each) NDC 69097-031-74; Inner carton: 28 capsules (4 blisters of 7 capsules) NDC 69097-031-56; Foil blister: NDC 69097-031-17 — Reason: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 100 Towelettes, Manufactured by: Acme United Corporation, 1 Waterview Dr, Shelton, CT 06481, NDC 0924-0246-01. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Dynarex, BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 5x7, 1000 packets, 5x7, Manufactured for Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962,USA, NDC 67777-245-04. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoThe Harvard Drug Group LLC recall (Cls II)Novugen Pharma (Malaysia) Sdn Bhd

    Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06. — Reason: Defective container; inadequately sealed blister packaging. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoHarbin Jixianglong Biotech Co., Ltd. recall (Cls II)Novo Nordisk AS

    Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04; e) 100g, NDC 84385-106-05Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China. — Reason: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoRising Pharma Holding, Inc. recall (Cls II)CHINA PHARMA HOLDINGS, INC.

    Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51. — Reason: Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    First Aid Only BZK Antiseptic Towelette (Benzalkonium Chloride 0.13%), 5x7, bulk, Acme United Corporation, 2280 Tanner Road, Rocky Mount, NC, 27801 Made in USA, NDC 0924-7116-00. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoNew Life Pharma LLC recall (Cls II)Lifestar Pharma LLC

    Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06 — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Wipes Plus, Hand Sanitizing Alcohol Free BZK Wipes (Benzalkonium Chloride 0.13%), Manufactured for: CFS Brands DBA WipesPlus, 4711 E. Heiner Rd. Oklahoma City, OK 73331, NDC 67151-333-01. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    First Aid Only BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 50 Wipes, NDC 0924-7116-03. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoHTO Nevada Inc. dba Kirkman recall (Cls II)Sustained Therapeutics Inc

    FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016. — Reason: Stability Data Does Not Support Expiry Date. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoHTO Nevada Inc. dba Kirkman recall (Cls II)International Medication Systems Ltd

    MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015. — Reason: Stability Data Does Not Support Expiry Date. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Med-Nap Cleansing Towelettes (Benzalkonium Chloride 0.13%), 100 Towelettes, Manufactured by: Acme United Corporation, 1 Waterview Dr., Stelton, CT 06484, NDC 0924-0243-01. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Savannah Antibacterial Towelettes (Benzalkonium Chloride 0.13%), 1 towelette, 4 x 7, R&R Enterprise, NDC 59647-749-02 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoMohamed Hagar recall (Cls I)Shenzhen Hanhui Pharmaceutical Technology Co Ltd

    Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0 — Reason: Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule). — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoNew Life Pharma LLC recall (Cls II)Lifestar Pharma LLC

    Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04. — Reason: Lack of Assurance of Sterility — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 5" x7", 1000 ea Bulk, Med-Nap, Brooksville, FL 34601, Made in USA, NDC 0924-0246-02. — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    Hand Sanitizing Wipes (Benzalkonium Chloride 0.13%), 1000 per case, Acme United Corporation, 2280 Tanner Road, Rocky Mount, NC 27801, NDC 0924-0301-00 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoHTO Nevada Inc. dba Kirkman recall (Cls II)Sustained Therapeutics Inc

    MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014. — Reason: Stability Data Does Not Support Expiry Date. — Status: Ongoing

    full page →fda recalls ↗
    ›Mar 11, 2026recall157d agoACME UNITED CORPORATION recall (Cls II)ACME UNITED CORP

    First Aid Only BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 100 Wipes, NDC 0924-7116-04 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ← prev
    page 9 of 151
    next →
    $CPHI0.7101-0.82%
    $ACU45.90-1.54%
    $ABBV249.46-0.54%
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $BLRX2.7600+1.52%
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $ACU45.90-1.54%
    $ACU45.90-1.54%